Építés alatt – nem éles oldal
Belépés

579 open Melanóma trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

OrszágOpen trials
Egyesült Államok268
Kína70
Franciaország61
Olaszország61
Spanyolország50
All other countries

The same trial often runs in several countries

A Double-Blind, Randomized, Three-arm, Active-Controlled, Parallel-Group, Phase 1 Study Evaluating Pharmacokinetic Similarity of Three Formulations of Pembrolizumab (CT-P51, EU-approved Keytruda, and US-licensed Keytruda) as Adjuvant Therapy in Patients with Completely Resected Stage IIB, IIC, and III Melanoma has 1 site in Horvátország and runs in 6 countries. If a site near you is full, another one may still take people.

See A Double-Blind, Randomized, Three-arm, Active-Controlled, Parallel-Group, Phase 1 Study Evaluating Pharmacokinetic Similarity of Three Formulations of Pembrolizumab (CT-P51, EU-approved Keytruda, and US-licensed Keytruda) as Adjuvant Therapy in Patients with Completely Resected Stage IIB, IIC, and III Melanoma in all 6 countries
Építés alatt, nem éles – Melanóma: vizsgálatok itt: Horvátország – Frontlight Research